Felix™ System Gains Momentum in Japan: New Orders Surge
We're thrilled to announce a surge in orders for our innovative Felix™ System in Japan, marking a significant milestone…
Advancing Partnership: Memphasys Director of Operations Visits Manufacturing Partner Ahead of Major Orders
Memphasys Associate Professor Hassan Bakos PhD MBA, our Director of Operations, paid a visit to our FelixTM device…
Memphasys visits Monash IVF. Cementing our clinical Partnership
Dr David Ali, Director of Operations of Memphasys, recently visited the Monash IVF team in Melbourne, marking a pivotal…
The gathering storm: One in twenty men are infertile
"The human male was not a very fertile individual. Roughly one in 20 is infertile ... An old lecturer of mine used to…
Watch: The future of infertility treatment
Dr Ramya Jayaram addressed ASPIRE 2023, the 12th Congress of the Asia Pacific Initiative on Reproduction, to present…
FelixTM: Viewpoint from Japan
As the first major global commercial agreement to sell and distribute the FelixTM sperm separation device goes from…
Memphasys accelerates commercial approval for sperm-separation device
Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…
Why FelixTM is big in Japan
Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…
Fantastic Austrade support for Felix in Japan
Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…
Watch: Understanding male fertility
Laureate Professor John Aitken, Scientific Director at Memphasys, and Professor Robert McLachlan, Endocrinologist and…